RxDoctor Payments Data

David Gast, MD

Physical Medicine & Rehabilitation · Auburn, MENPI 1518953934

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $116 and has fallen 84.9% since, to $18 in 2023.

$334in general payments, 2019–2025

Across 21 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$63
  • AbbVie$58
  • Teva Pharmaceuticals USA, Inc.$43
  • Pfizer$28
  • Novo Nordisk$28
  • Boehringer Ingelheim$25
  • plus $90 from 6 others

What the payments were for

  • Food & beverage$334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$334 in reported general payments places this provider in the 80th percentile of 34 physical medicine & rehabilitation providers in Maine.

See all physical medicine & rehabilitation providers in Maine

Medicare billing

Part B allowed, 2024
$33,801
Medicare patients
230
Services billed
544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin86$1,107
Pregabalin28$907
Baclofen24$615
Tizanidine Hcl25$271
Prednisone34$141
Lamotrigine27$124
Morphine Sulfate13$61
Tramadol Hcl14$41

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Auburn

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →